Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | CES2 | O00748 | 5/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 5/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.36 |
| ▸ | CES1 | P23141 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.34 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.33 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARD | Q03181 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19858539 | 0.96 | FAAH (0.39) | FAAHALDH1A1CES2EPHX1PTGS2 | |
| SCHEMBL7058616 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL7775373 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL3237379 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL1041201 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL7058668 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL3793805 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL6324952 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL27959383 | 0.88 | FAAH (0.43) | FAAHALDH1A1CES2EPHX1CES1 | |
| SCHEMBL1535144 | 0.86 | ALDH1A1 (0.43) | FAAHALDH1A1CES2EPHX1CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10316046-B2 | Method for producing acyloxysilanes, acyloxysilanes obtained thereby, and use of same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2019-06-11 | — | — | US | disclosed |
| US-20180044359-A1 | Method for Producing Acyloxysilanes, Acyloxysilanes Obtained Thereby, and Use of Same | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180044359-A1 | Method for Producing Acyloxysilanes, Acyloxysilanes Obtained Thereby, and Use of Same | COASY, AGPS, CA7 | FAAH 510/4885ALDH1A1 176/4885CES2 133/4885 |
| US-10316046-B2 | Method for producing acyloxysilanes, acyloxysilanes obtained thereby, and use of same | COASY, AGPS, CA7 | FAAH 510/4885ALDH1A1 176/4885CES2 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.